Suchergebnisse - "Majbour, Nour"

PubPharm (77)

1

Retraction Notice to : Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders

enthalten in: Molecular therapy : the journal of the American Society of Gene Therapy | 2024

von Javed, H. | Menon, S. | Al-Mansoori, K. | +8

RetractionOf: Mol Ther. 2016 Apr;24(4):746-58. - PMID 26700614

2

Retraction Notice to : Corrigendum to "Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders"

enthalten in: Molecular therapy : the journal of the American Society of Gene Therapy | 2024

von Javed, H. | Menon, S. | Al-Mansoori, K. | +8

RetractionOf: Mol Ther. 2016 Apr;24(4):746-58. - PMID 26700614

3

Uncovering a neurological protein signature for severe COVID-19

enthalten in: Neurobiology of disease | 2023

von El-Agnaf, O. | Bensmail, I. | Al-Nesf, M. | +16

4

Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease

enthalten in: Brain : a journal of neurology | 2023

von Mok, T. | Nihat, A. | Majbour, N. | +30

CommentIn: Brain. 2023 May 10;:. - PMID 37161596

5

Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up

enthalten in: Neurobiology of disease | 2023

von Abdi, I. | Bartl, M. | Dakna, M. | +5

6

Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers

enthalten in: International journal of molecular sciences | 2022

von Vaikath, N. | Sudhakaran, I. | Abdi, I. | +6

7

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage

enthalten in: Neurology | 2022

von Majbour, N. | Aasly, J. | Abdi, I. | +4

8

Trajectories of neurodegeneration and seed amplification biomarkers prior to disease onset in individuals at risk of prion disease

enthalten in: bioRxiv.org | 2022

von Mok, T. | Nihat, A. | Majbour, N. | +30

9

DNA APTAMERS AND COMPOSITIONS TARGETING ALPHA-SYNUCLEIN AND METHODS OF MAKING AND USING SAME

enthalten in: Europäisches Patentamt | 2022

von HMILA ISSAM | MAJBOUR NOUR KHALED | EL-AGNAF OMAR

10

Novel engineered nanobodies specific for N-terminal region of alpha-synuclein recognize Lewy-body pathology and inhibit in-vitro seeded aggregation and toxicity

enthalten in: The FEBS journal | 2022

von Hmila, I. | Vaikath, N. | Majbour, N. | +11

1
2
3
4
5
6
7
8
Nächster »
[8]